Evidence map›Paper›PMID 39736509›Full record

ArticleBMC cardiovascular disorders2024

Clinical features and prognostic factors of cardiorenal anemia syndrome in China: a retrospective single-center study.

Mengyue Zhu, Min Liu, Chunlei Lu, Dafeng He, Jiao Li, Xia Xu, Ying Cui, Chuanyan Zhao, Jun Xu, Gang Zhou and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cardiovascular disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mengyue Zhu *Nephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China.
Min Liu *The Affiliated Suqian Hospital of Xuzhou Medical University and Nanjing Drum Tower Hospital Group Suqian Hospital, Suqian, China.
Chunlei LuNephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China.
Dafeng HeNephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China.
Jiao LiNephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China.
Xia XuNephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China.
Ying CuiNephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China.
Chuanyan ZhaoNephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China.
Jun XuNephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China.
Gang ZhouNephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China.
Hongbin MouNephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China.
Guangyu BiNephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China.
Changhua LiuNephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China.
Rong WangNephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China. wenduan0306@126.com.

Funding

Hospital Research Project FCJS202340Scientific Research Project of Jiangsu Provincial Healthcare Commission Z2022068
6 · The paper itself

Abstract

backgroundThere is little research on cardiorenal anemia syndrome (CRAS) in China. This study was to describe the characteristics of patients with CRAS and to explore risk factors of all-cause death.

methodsA total of 81,795 patients were hospitalized from August 2012 to August 2021 in the nephrology department and cardiology department, of which 820 patients with CRAS were recruited into this study. The 820 patients were divided into three groups based on New York Heart Association (NYHA) functional class: a NYHA Class II group (n = 124), a NYHA Class III group (n = 492), and a NYHA Class IV group (n = 204). Demographics and laboratory tests were collected and risk factors of all-cause death were analyzed. The primary endpoint of the study was all-cause death.

results820 patients were included, with a median age of 65.00 (51.00-75.00) years and 61.2% were men. The median follow-up was 27.0 (13.0-51.0) months. 416 (50.7%) patients died during follow-up. Age, smoking history, cerebral infarction, NYHA functional class, albumin, serum creatinine (SCr), left ventricular end-diastolic diameter (LVEDD), and left ventricular ejection fraction (LVEF) remained independent predictors of all-cause mortality risk in patients with CRAS (P < 0.05) after adjusting to the potential confounders.

conclusionsIn patients with CRAS, older age, smoking history, and more advanced systolic heart failure and renal failure correlated with worse clinical outcomes at follow-up.

Indexed as

Cardio-Renal SyndromeCause of DeathAgedChinaFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsAnemiaChronic kidney diseaseCRASHeart failurePrognosis factors

Identifiers

PMID39736509
PMCPMC11686829

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.